- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 8.09M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 7.44M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $202K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $46K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$26.13M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$15.95M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $221.65M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $228.4M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $76.82M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $76.72M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $51.51M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $86.89M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $43.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$15.42M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $30.47M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $125.85M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $146.44M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $359.35M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $387.55M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $111.74M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $149.48M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $320.33M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $404.97M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$5.82 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$2.14 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$5.82 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$2.14 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $16.79M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $16.57M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$47.07M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$15.88M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$51.04M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$13.13M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $13.86M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $46.08M |
| Revenue | Q1 2026 · Mar 31, 2026 | $37.23M |
| Revenue | Q1 2026 · Mar 31, 2025 | $74.51M |